MedPath
Found 43 clinical trials|View Analysis
Sort by:

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Recruiting
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders
Schizophrenia
Delusional Disorder
Bipolar 1 Disorder
Schizoaffective Disorder
Psychosis Not Otherwise Specified
Early Psychosis
First Posted Date
2024-12-18
Last Posted Date
2024-12-18
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
320
Registration Number
NCT06740383
Locations
🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

🇺🇸

University of Georgia, Athens, Georgia, United States

🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

and more 3 locations

Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia

Not yet recruiting
Conditions
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders
First Posted Date
2024-11-05
Last Posted Date
2024-12-10
Lead Sponsor
Not specified
Target Recruit Count
200
Registration Number
NCT06673966

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Not Applicable
Recruiting
Conditions
Severe Mental Disorder
Metabolic Complication
Side-Effect;Medication
Schizophrenia Spectrum and Other Psychotic Disorders
Bipolar Disorder
Interventions
Other: Treatment in the Meta Care Clinic
Other: Standard care with general practitioner and/or outpatient clinics
First Posted Date
2024-10-03
Last Posted Date
2024-10-03
Lead Sponsor
Bjorn H. Ebdrup
Target Recruit Count
80
Registration Number
NCT06624462
Locations
🇩🇰

Centre for Neuropsychiatric Schizophrenia Research, CNSR, Mental Health Centre Glostrup, Glostrup, Capital Region, Denmark

The Personalized Psychological Treatment for Psychosis

Not Applicable
Not yet recruiting
Conditions
Schizophrenia
Psychosis
Schizophrenia Spectrum and Other Psychotic Disorders
Interventions
Behavioral: Psychological treatment (P-MCT)
Behavioral: Psychological treatment (MCT)
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
Polish Academy of Sciences
Target Recruit Count
252
Registration Number
NCT06603922
Locations
🇨🇱

Universidad de Valparaíso, Valparaíso, Chile

🇫🇷

University Hospitals of Strasbourg, Strasbourg Cedex, France

🇩🇪

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

and more 3 locations

SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

Not Applicable
Recruiting
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders
Affective Psychoses
Interventions
Other: SloMo
First Posted Date
2024-08-23
Last Posted Date
2024-12-20
Lead Sponsor
King's College London
Target Recruit Count
150
Registration Number
NCT06568081
Locations
🇬🇧

South London and Maudsley NHS Foundation Trust, London, United Kingdom

VR-based Avatar Therapy for Treatment of Auditory Hallucinations

Not Applicable
Recruiting
Conditions
Hallucinations, Auditory
Schizophrenia Spectrum and Other Psychotic Disorders
Interventions
Behavioral: AVATAR therapy
First Posted Date
2024-07-17
Last Posted Date
2024-07-19
Lead Sponsor
Semmelweis University
Target Recruit Count
90
Registration Number
NCT06505564
Locations
🇵🇱

Uniwersytet Medyczny w Łodzi, Łódź, Poland

🇪🇸

Unitat de Recerca del Parc Sanitari Sant Joan de Déu, Barcelona, Spain

🇪🇸

University of Barcelona, Barcelona, Spain

and more 1 locations

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

Not Applicable
Recruiting
Conditions
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Schizophreniform Disorders
Brief Psychotic Disorder
Delusional Disorder
Schizoaffective Disorder
Interventions
Behavioral: Cognitive Remediation (REHACOP)
Behavioral: Metacognitive Training (MCT)
First Posted Date
2024-05-21
Last Posted Date
2024-05-23
Lead Sponsor
Universitat Autonoma de Barcelona
Target Recruit Count
160
Registration Number
NCT06423651
Locations
🇪🇸

Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Barcelona, Spain

Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients

Completed
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders
Periodontal Diseases
Interventions
Drug: antipsychotic drugs inducing hyperprolactinemia
First Posted Date
2023-09-18
Last Posted Date
2023-09-18
Lead Sponsor
Fayoum University
Target Recruit Count
64
Registration Number
NCT06040944
Locations
🇪🇬

Rania Hassan Shalby, Giza, Egypt

Sex, Psychopharmacology, and Diabetes

Not Applicable
Recruiting
Conditions
Diabetes Mellitus
Sexual Dysfunction
Schizophrenia Spectrum and Other Psychotic Disorders
Drug-Related Side Effects and Adverse Reactions
Schizophrenia
PreDiabetes
Education
Interventions
Behavioral: Educational intervention
First Posted Date
2023-07-19
Last Posted Date
2023-09-22
Lead Sponsor
Zealand University Hospital
Target Recruit Count
192
Registration Number
NCT05951660
Locations
🇩🇰

Assertive Community Centres, Slagelse, Denmark

EPI-MINN: Targeting Cognition and Motivation - National

Not Applicable
Recruiting
Conditions
Psychosis Nos/Other
Bipolar Disorder
Psychosis
Schizoaffective Disorder
Schizophrenia Spectrum and Other Psychotic Disorders
Schizophrenia
Schizo Affective Disorder
Prodromal Schizophrenia
Schizophreniform Disorders
Major Depression With Psychotic Features
Interventions
Device: Cognitive and Social Cognitive Training
Behavioral: Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App
Other: Early Psychosis Coordinated Specialty Care
First Posted Date
2023-05-26
Last Posted Date
2024-12-11
Lead Sponsor
University of Minnesota
Target Recruit Count
200
Registration Number
NCT05877716
Locations
🇺🇸

University of Minnesota Department of Psychiatry & Behavioral Sciences, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath